Your browser doesn't support javascript.
loading
Molecular Pathology of Myeloid Neoplasms: Molecular Pattern Recognition.
Sadigh, Sam; Kim, Annette S.
Affiliation
  • Sadigh S; Department of Pathology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.
  • Kim AS; Division of Diagnostic Genetics and Genomics, Department of Pathology, University of Michigan/Michigan Medicine, 2800 Plymouth Road, NCRC 36-1221-79, Ann Arbor, MI 48109, USA. Electronic address: kimannet@med.umich.edu.
Clin Lab Med ; 44(2): 339-353, 2024 Jun.
Article in En | MEDLINE | ID: mdl-38821648
ABSTRACT
Despite the apparent complexity of the molecular genetic underpinnings of myeloid neoplasms, most myeloid mutational profiles can be understood within a simple framework. Somatic mutations accumulate in hematopoietic stem cells with aging and toxic insults, termed clonal hematopoiesis. These "old stem cells" mutations, predominantly in the epigenetic and RNA spliceosome pathways, act as "founding" driver mutations leading to a clonal myeloid neoplasm when sufficient in number and clone size. Subsequent mutations can create the genetic flavor of the myeloid neoplasm ("backseat" drivers) due to their enrichment in certain entities or act as progression events ("aggressive" drivers) during clonal evolution.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Myeloproliferative Disorders Limits: Humans Language: En Journal: Clin Lab Med Year: 2024 Document type: Article Affiliation country: United States Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Myeloproliferative Disorders Limits: Humans Language: En Journal: Clin Lab Med Year: 2024 Document type: Article Affiliation country: United States Country of publication: United States